Diagnosing and Treating Immune Thrombocytopenic Purpura
The group continues their analysis of emergencies by exploring their first hematologic emergency: Immune thrombocytopenic purpura (ITP). They explain how to confirm that the diagnosis is in fact ITP, and subsequently, provide a treatment plan.
BREAKWATER Trial: Encorafenib Plus Cetuximab With FOLFIRI Shows Strong Efficacy in BRAF V600E-mutant mCRC
T-DXd with Fluoropyrimidine and Pembrolizumab Shows Strong Antitumor Activity in Advanced HER2+ Gastric, Esophageal Cancers
CABINET: Updated PFS, Subgroup Analyses of Cabozantinib Versus Placebo for Advanced NET